New report published by Grand View Research on Global Urethane Adhesives Market summarizes that, trend shift towards adoption of urethane adhesives over acrylic and epoxy, owing its better compatibility, elasticity and flexibility with substrates such as plastics, glass, wood and concrete is expected to complement the market growth during the forecast period.

Growth in infrastructure spending, particularly in emerging BRIC markets is expected to remain a key driving force for the global urethane adhesives market. A trend shift towards adoption of urethane adhesives over acrylic and epoxy, owing its better compatibility, elasticity and flexibility with substrates such as plastics, glass, wood and concrete is also expected to complement the market growth. Urethane adhesives are expected to penetrate household, commercial and industrial markets which are expected to broaden their scope in the overall market. In addition, growth of major end-use industries such as footwear and home care particularly, in high growth markets of China and India is also expected to spur industry demand.

Full research report on Global Urethane Adhesives Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/urethane-adhesives-market

High quality and minimum to zero maintenance of urethane adhesives has helped urethane adhesives to penetrate the overall adhesives industry. Volatile feedstock prices and environmental regulations on hazardous content remained a key issue for market participants. Major manufacturers have increased their R&D expenditure in order to provide sustainable solutions to urethane adhesives using bio-based routes.

Get more information on Global Urethane Adhesives Market or request for TOC of this research report at:
http://www.grandviewresearch.com/industry-analysis/urethane-adhesives-market/request-toc

Asia Pacific emerged as the leading regional market for urethane adhesives followed by Europe and North America. Growth of construction, transportation and home furnishing industry is expected to boost the Asia Pacific urethane adhesives market over the forecast period. North America and Europe are matured markets for urethane adhesives and are driven mainly by the development of green adhesives. Adhesives manufacturers invested on the R&D to incorporate bio-based urethane adhesives to steer clear of conventional urethane hazardous contents. Some of the key market participants include BASF, 3M Company, The Dow Chemicals, Henkel AG & Co. KGaA, H.B Fuller Company, RPM International, Inc., Lord Corporation and E. I. du Pont de Nemours and Company.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information, visit: http://www.grandviewresearch.com/

Blog: http://www.mediafound.org/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430306762.jpeg

“Grand View Research, Inc. – Market Research And Consulting.”

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Email: haakon@grandviewresearch.com
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/urethane-adhesives-market

Source: ABNewswire

ReleaseID: 27449

RadiantInsights.com has announced the addition of “Global Psoriasis Therapeutics Market To 2015-2019: Radiant Insights, Inc” Market Research Report to their Database.

About Psoriasis and Its Types

Psoriasis is a common immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes buildup of thick white, red, or silvery patches of skin. It alters the normal cell cycle of the skin. The new cells of the skin grow and move quickly to the surface of the skin to form patches known as “plaques”. The plaques are commonly found on knees, elbows, scalp, hands, and feet. Psoriasis occurs mostly in adults, but can also be seen in children and adolescents. The etiology of the disease is unknown, however, it is believed to be an immune-mediated process. It is believed that the over-activity of the immune system can cause inflammation, thereby resulting in flaking of the skin.

View Full Report with TOC at:
http://www.radiantinsights.com/research/global-psoriasis-therapeutics-market-2015-2019

TechNavio’s analysts forecast the Global Psoriasis Therapeutics market to grow at a CAGR of 9.95 percent over the period 2014-2019.

Covered in this Report:

This report covers the present scenario and the growth prospects of the Global Psoriasis Therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs including systemic and topical drugs used in the treatment of:

• Psoriasis
• Psoriatic Arthritis

The Global Psoriasis Therapeutics market is segmented based on the mechanism of action of the drugs used to treat psoriasis and psoriatic arthritis as illustrated below:

• TNF Inhibitors
• PDE4 Inhibitors
• Interleukin Blockers
• Others

The Global Psoriasis Therapeutics market is also segmented based on the type of molecule used for the treatment of psoriasis, as illustrated below:

• Biologics
• Small Molecules

On the basis of route of administration adopted for the treatment of psoriasis, the Global Psoriasis Therapeutics market is segmented as follows:

• Oral
• Parenteral
• Topical

See More Reports of This Category by Radiant Insights at:
http://www.radiantinsights.com/catalog/food

The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Psoriasis Therapeutics market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. In addition, late-stage pipeline molecules developed for the treatment of psoriasis have been discussed.

TechNavio’s report, Global Psoriasis Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and the EMEA regions; it also covers the Global Psoriasis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions:

• Americas:
? APAC
? EMEA

Key Vendors

• Abbvie
• Amgen
• Janssen Pharmaceuticals
• Pfizer

Other Prominent Vendors

• AbGenomics
• Almirall
• Anacor Pharmaceuticals
• ApoPharma
• Astellas Pharma
• AstraZeneca
• Aurinia Pharmaceuticals
• Biocon
• Biogen Idec
• Biotest
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Can-Fite BioPharma
• Celgene
• Coherus Biosciences
• Creabilis
• Dermira
• Eli Lilly
• F. Hofffmann-La Roche
• Forward Pharma
• G & W Laboratories
• GlaxoSmithKline
• Idera Pharmaceuticals
• Kadmon
• Kyowa Hakko Kirin
• LEO Pharma
• Maruho
• Merck
• Moleculin
• MorphoSys
• Novartis
• Pfizer
• Promius Pharma
• Provectus Biopharmaceuticals
• Sandoz
• Sun Pharmaceuticals
• Takeda Pharmaceutical
• Taro Pharmaceuticals
• Therapeutics Inc.
• UCB
• Valeant Pharmaceuticals
• VBL Therapeutics

Market Driver

• Growing Unmet Needs
• For a full, detailed list, view our report

Market Challenge

• Unknown Disease Etiology
• For a full, detailed list, view our report

Market Trend

• Market Dominance by Biologics
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
• You can request one free hour of our analyst’s time when you purchase this market report.

Details are provided within the report.

Latest Report by Radiant Insights

Global Childrens Wear Market To 2014-2018:
http://www.radiantinsights.com/research/global-children-s-wear-market-2014-2018

TechNavio’s analysts forecast the Global Children’s Wear market to grow at a CAGR of 5.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing consumer spending on children’s wear. The Global Children’s Wear market has also been witnessing the increasing demand for luxury children’s wear in developed economies. However, the increasing vendor competition could pose a challenge to the growth of this market.

Global and Chinese Black Tea Flavor Market To 2009-2019:
http://www.radiantinsights.com/research/global-and-chinese-black-tea-flavor-industry-2009-2019-market-research-report

The ‘Global and Chinese Black Tea Flavor Industry, 2009-2019 Market Research Report’ is a professional and in-depth study on the current state of the global Black Tea Flavor industry with a focus on the Chinese market. The report provides key statistics on the market status of the Black Tea Flavor manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For More Information, Visit: http://www.radiantinsights.com/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430288974.jpeg

“Radiant Insights Logo”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/global-psoriasis-therapeutics-market-2015-2019

Source: ABNewswire

ReleaseID: 27447

Grand View Research has published a new report about The Global Egg Protein Market and suggest that the global market is expected to witness growth on account of the growing demand for nutritional supplement in food & beverage industry.

Egg protein market is expected to witness growth on account of growing demand for nutritional supplement in food & beverage industry. Growth in protein consumption is expected to play an important role in driving egg protein market growth in the near future. Changing food habits and growing awareness towards nutritional food in emerging markets such as China and India is expected to have a positive impact on market growth over the forecast period. Food & beverage industry growth in India, Brazil and China is expected to drive egg protein market in the near future.

Full research report on Global Egg Protein Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/egg-protein-market

Improved sports infrastructure as a result of increased sporting activities including Soccer World Cup 2014 and Summer Olympics 2016 is expected to increase sales of food supplements such as egg protein. Brazilian sports industry is expected to grow at an average rate of 7.4% and would have impact on egg protein market growth. Growing egg product demand for domestic consumption coupled with technology advancement has resulted in increased number of egg processing plants in Japan. Daiichi-Kasei, Kewpie Egg Corporation and Taiyo Kagaku Co. Ltd are major egg protein manufacturers situated in Japan. Daiichi-Kasei has a manufacturing facility located at Yamashina and markets products from food protein materials business division.

Get more information on Global Egg Protein Market or request for TOC of this research report at:
http://www.grandviewresearch.com/industry-analysis/egg-protein-market/request-toc

Growing poultry industry in India is expected to positively impact market growth. Indian egg production witnessed a growth from 30 billion in 2000 to 200 billion in 2012 and is expected to further increase over the next six years due to surging domestic demand. Growing egg production is expected to ensure raw material availability for egg protein production.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information, visit: http://www.grandviewresearch.com/

Blog: http://www.altubina.com/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430308036.jpeg

“Grand View Research, Inc. – Market Research And Consulting.”

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Email: haakon@grandviewresearch.com
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/egg-protein-market

Source: ABNewswire

ReleaseID: 27443

New Market Research Reports Title “Colorectal Cancer Therapeutics Market Is Expected to Grow at CAGR 1.8% from 2020: Radiant Insights” Has Been Added to RadiantInsights.com Report Database.

GBI Research, the leading business intelligence provider, has released its latest research, “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 – Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in the eight major geographies of the US, Canada, the UK, France, Germany, Spain, Italy and Japan. The report provides an estimation of the market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth pipeline analysis, and deal analysis.

Browse Full Report With TOC at:
http://www.radiantinsights.com/research/colorectal-cancer-therapeutics-in-major-developed-markets-to-2020-increased-uptake-of-high-priced-drugs-to-offset-the-impact-of-generics

The CRC therapeutics market in the eight major markets is expected to grow at a Compound Annual Growth Rate (CAGR) of 1.8% to $9.4 billion by 2020. The US had the largest market share in 2013, equivalent to a global share of 44.1%, followed by Japan and Germany with 14.7% and 11.9% respectively. Spain had the lowest market share of the leading eight at 4.1%. All markets covered in the report are expected to witness a slower growth rate than Japan, which will grow at a CAGR of 5%. However, this moderate growth will be stymied by the expected uptake of lower-priced biosimilar versions of bevacizumab and cetuximab due to the expiration of the patents of Avastin and Erbitux in the latter half of the forecast period. Also expected is the launch of generic versions of capecitabine, which will also affect the market. However, this will be offset by the launch of premium-priced emerging therapies. Stivarga is expected to be one of the biggest drivers of growth in the CRC market, primarily due to its expected line extension in the first-line metastatic setting as a maintenance treatment for patients with resected liver metastases. The launch of Lonsurf (TAS-102), approved in Japan in 2014, in the third- and fourth-line settings will further increase the pharmacological treatment rates in these lines, which will give patients a more tolerable alternative to Stivarga. The moderate uptake of other late-stage pipeline products, panitumumab and Xilonix, following their expected approval, is expected to drive additional growth within this market.

The CRC pipeline is highly robust, with potential drug candidates across various Phases of clinical development. With nearly 400 active pipeline molecules, the majority of the investigational drug candidates are being evaluated for the treatment of CRC in advanced stages, either as first-line or second-line therapies. The current investigational pipeline candidates include new combination therapies and targeted therapies, as well as promising immunotherapies and chemotherapy drug candidates. As well as these active progressing pipeline molecules, the pipeline also includes nearly 180 molecules that are either inactive or discontinued.

Scope

The report analyzes treatment usage patterns, market characterization, the pipeline, and key licensing and co-development deals in the eight major markets: the US, the UK, France, Germany, Spain, Italy, Japan and Canada.

It includes —

• A brief introduction to CRC, including the disease’s pathogenesis, etiology, diagnosis and treatment algorithms
• In-depth analysis of currently marketed drugs for CRC, examining their safety, efficacy, treatment patterns and strengths/weaknesses and including a heat map that compares the drugs in terms of safety and efficacy
• A comprehensive review of the pipeline for CRC, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market during the forecast period; the pipeline is analyzed on the basis of Phase distribution, molecule type, program type, mechanism of action and molecular target
• Additional in-depth analysis of pipeline drug clinical trials by Phase, trial size, trial duration and program failure rate for each molecule type
• Multi-scenario forecast data of the market to 2020, taking into account how the market may be affected by the introduction of new drugs, the expiry of key patents on current drugs and the changes in disease epidemiology across the key developed markets
• Discussion of the drivers of and barriers to market growth
• In-depth analysis of all licensing and co-development deals that have occurred in the CRC market since 2006

Explore More Reports on Cancer Therapeutics Market at:
http://www.radiantinsights.com/research/colorectal-cancer-therapeutics-in-major-developed-markets-to-2020-increased-uptake-of-high-priced-drugs-to-offset-the-impact-of-generics

Reasons to buy

The report will enhance your decision-making capability by allowing you to —

• Understand the CRC pipeline and the factors that indicate that it is becoming more innovative
• Examine detailed profiles of promising pipeline products and gain an insight into how they are likely to compete in the market and who their main competitors will be
• Follow the trends in CRC clinical trial size and duration in relation to industry averages and assess the potential risk of future developmental programs according to mechanism of action by considering the recorded clinical trial failure rates
• Observe the potential growth patterns expected for the CRC market over the forecast period, identify which countries are expected to make the biggest contribution to this growth, and devise a more effective country strategy through an understanding of key drivers and barriers in the CRC market
• Accelerate and strengthen your market position by identifying key companies for strategic partnerships.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For More Information, Visit: http://www.radiantinsights.com/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430292163.jpeg

“Radiant Insights Logo”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/colorectal-cancer-therapeutics-in-major-developed-markets-to-2020-increased-uptake-of-high-priced-drugs-to-offset-the-impact-of-generics

Source: ABNewswire

ReleaseID: 27445